Regenerative Medicine in Medical – Thematic Research

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Regenerative Medicine in Medical Theme Analysis Report Overview

Regenerative medicine is an innovative field of medicine that holds the potential to fully cure diseases, eliminate cancer, and heal old and damaged tissue. Regenerative medicine is relevant to the orthopedic, cardiovascular, neurological, wound care, cancer, and pharmaceutical markets. The three main branches of regenerative medicine are gene therapy, cell therapy, and tissue repair. Currently, available gene therapies focus on curing rare diseases, but research is gaining traction in both prevalent and polygenic diseases. Market players in regenerative medicine range from large dominant corporations to small innovative start-ups. While the big-name corporations leverage their presence in relevant markets around the world, the start-ups continually develop novel technologies and expand regenerative medicine capabilities.

The Regenerative Medicine in Medical thematic intelligence report briefs about the types of regenerative medicine. It provides an overview of the current landscape, including healthcare, technology, regulatory, macroeconomic trends, and key players. The primary focus of this report is on regenerative medicine therapies that act as medical devices and are not strictly drug-related.

Report Pages 40
Regions Covered Global
Key Trends ·        Technology

·        Macroeconomic

·        Regulatory

Value Chain ·        Gene Therapies

·        Cell Therapies

·        Tissue Repair

Leading companies in Regenerative Medicine ·        Astellas Pharma

·        Bayer

·        Bristol Myers Squibb

·        Novartis

·        SanBio

Key Trends

The main trends shaping the Regenerative Medicine space in the medical industry are classified into three categories: technology trends, macroeconomic trends, and regulatory trends.

Technology trends – The report focuses on key technology trends impacting the regenerative medicine theme, which include gene therapy, cell therapy, and tissue repair.

Macroeconomic trends – The report analyses macroeconomic trends impacting the regenerative medicine theme, which include funding and clinical trials.

Regulatory trends – The report highlights the key regulatory trends issued by countries such as the US, Europe, Japan, China, and South Korea impacting the regenerative medicine theme.

Buy The full Report For More Insights On Key Trends Impacting Regenerative Medicine Theme In Medical Industry, Download A Free Report Sample

Regenerative Medicine in Medical - Value Chain Analysis

GlobalData’s regenerative medicine value chain in medical industry categorized into three major segments based on the form of the therapeutic agent used. They are gene therapies, cell therapies and tissue repair.

Gene therapies:As already discussed, gene therapies offer a unique opportunity to cure patients of disease and are often associated with a high price tag. High prices are arguably necessary when billing patients/payers for multiple treatments over longer periods of time, and they keep businesses running and drive R&D. There are many technical challenges in developing gene therapies, such as the host’s gene sequences, and gene editing facilitators, and gene vectors. Currently approved gene therapies are available for treating single-gene mutation diseases. Breaking into disease indications with multiple mutated genes will be a difficult challenge for developers.

Additionally, developers pay billions of dollars to license molecular technologies that facilitate their gene-editing technologies. The complex treatment must also be able to be packaged into size-limiting viral and non-viral vectors. Considering these developmental challenges, the high price tags are not unreasonable. Moving forward, it is still the onus of the developers to negotiate reasonable payment plans with payers and individuals so that these treatments can be accessed. Novartis and bluebird bio are currently working out payment plan details to increase patient access to these therapies. Bluebird bio has proposed an upfront payment of more than $340,000, followed by additional payments if the therapy is effective. Novartis is charging heavily for five years. The current market leaders in gene therapy are Novartis and BioMarin.

Regenerative medicine Value Chain in Medical

Regenerative medicine Value Chain in Medical

Buy The full Report For More Insights On Big Data Value Chain in Pharma, Download A Free Report Sample

Leading Companies in the Regenerative Medicine Theme

Some of the leading vendors making their mark within the regenerative medicine theme:

  • Astellas Pharma
  • Bayer
  • Bristol Myers Squibb
  • Novartis
  • SanBio

Buy The full Report For More Insights Companies in Regenerative Medicine Theme In Medical Industry, Download A Free Report Sample


This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.

The report covers the Regenerative Medicine theme.

Bluebird bio
Orchard Theraputics
W.L. Gore
Vericel Corp
Bayer AG

Table of Contents

Executive Summary


Technology/Thematic Briefing


Industry Analysis

Value Chain



Further Reading

Our Thematic Research Methodology

About GlobalData

Contact Us

Frequently asked questions

Regenerative Medicine in Medical – Thematic Research thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Regenerative Medicine in Medical – Thematic Research was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Regenerative Medicine in Medical – Thematic Research in real time.

  • Access a live Regenerative Medicine in Medical – Thematic Research dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.